Cargando…
Radium-223 chloride: a potential new treatment for castration-resistant prostate cancer patients with metastatic bone disease
BACKGROUND: Radium-223 chloride ((223)Ra; Alpharadin) is an alpha-emitting radioisotope that targets areas of osteoblastic metastasis and is excreted by the small intestine. When compared with beta-emitters (eg, strontium-89, samarium-153), (223)Ra delivers a high quantity of energy per track length...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544343/ https://www.ncbi.nlm.nih.gov/pubmed/23326203 http://dx.doi.org/10.2147/CMAR.S25537 |